Grace Nambatya Kyeyune

Grace Nambatya Kyeyune (née Grace Nambatya) (born April 1962) is a Ugandan medicinal chemist, researcher and academic, who serves as the director of research at the National Chemotherapeutic Research Institute (NCRI), based in Kampala, Uganda's capital city. According to its website, NCRI is a state-owned "research and development institute in natural products and traditional and complementary health systems". As of July 2021, Nambatya is credited with developing five compounds, currently in clinical and public use, which are extracted from Ugandan plants and herbs.

Nambatya's research is credited with bringing several compounds to market during the COVID-19 pandemic. These include the following:

UBV-01N A natural formulation developed by Nambatya and her team at NCRI. Since January 2021 it is undergoing human clinical trials at Mulago National Referral Hospital.

Excel Sanitizer The formulation contains Warburgia ugandensis, which is both antibacterial and antifungal.

Warbugia Herbal Cough Syrup Under development as a cough remedy for COVID-19 patients.

NCRI Immuno Booster An organic drink under development to fortify body immunity to resist infections in general and viral attacks, in particular.

Family Nambatya is married to Robert Kyeyune and together, they are the parents of five children.

Other considerations Nambatya lectures I nchemistry at the College of Natural Sciences and pharmacy at the College of Health Sciences, both at Makerere University, the oldest and largest public university in Uganda.

She also sits on the board of the National Drug Authority, since 2008. She is the chair of the Public Private Partnership for Health (PPPH) Working Group. She is also a member of the Top Management Team at the Uganda Ministry of Health, answerable directly to the Permanent Secretary.